Home > Healthcare > Live cell encapsulation Market > Table of Contents

Live cell encapsulation Market - by Polymer Type (Natural {Alginate, Chitosan}, Synthetic), By Method (Microencapsulation, Macroencapsulation, Nanoencapsulation), By Application (Drug Delivery, Cell Transplantation) & Forecast, 2023 – 2032

  • Report ID: GMI5684
  • Published Date: May 2023
  • Report Format: PDF

Report Content

Chapter 1   Methodology & Scope

1.1    Market scope & definition

1.2    Base estimates & calculations

1.3    Forecast parameters

1.4    COVID-19 impact analysis at global level

1.5    Data validation

1.6    Data Sources

1.6.1    Primary

1.6.2    Secondary

1.6.2.1   Paid sources

1.6.2.2   Unpaid sources

Chapter 2   Executive Summary

2.1    Live cell encapsulation industry 360synopsis, 2018 – 2032

2.1.1    Business trends

2.1.2    Regional trends

2.1.3    Polymer type trends

2.1.4    Method trends

2.1.5    Application trends

2.1.6    End-use trends

Chapter 3   Live Cell Encapsulation Industry Insights

3.1    Industry ecosystem analysis

3.2    Industry impact forces

3.2.1    Growth drivers

3.2.1.1   Increasing public-private investments to support product development

3.2.1.2   Rising prevalence of target diseases

3.2.1.3   Growing awareness among population pertaining the role of encapsulated cell in disease management

3.2.1.4   Increasing adoption of live cell encapsulation in regenerative medicine and therapeutic purposes

3.2.2    Industry pitfalls & challenges

3.2.2.1   High product manufacturing costs

3.2.2.2   Limited availability of good quality raw material

3.3    Growth potential analysis

3.3.1    By polymer type

3.3.2    By method

3.3.3    By application

3.4    COVID- 19 impact analysis

3.5    Methods and materials used in cell encapsulation

3.6    Cell encapsulated formulations for therapeutic applications

3.6.1    Microencapsulated microorganism formulations for therapeutic applications

3.6.2    Microencapsulated Mammalian Cell Formulations for Therapeutic Applications

3.7    Porter's analysis

3.8    PESTEL analysis

Chapter 4   Competitive Landscape, 2022

4.1    Introduction

4.2    Company matrix analysis, 2022

4.3    Competitive analysis of major market players

4.4    Competitive positioning matrix

4.5    Strategy dashboard

4.6    Strategic outlook matrix

Chapter 5   Live Cell Encapsulation Market Size and Forecast, By Polymer Type (USD Million)

5.1    Key trends, by polymer type

5.2    Natural Polymers

5.2.1    Alginate

5.2.2    Chitosan

5.2.3    Cellulose

5.2.4    Others

5.3    Synthetic Polymers

Chapter 6   Live Cell Encapsulation Market Size and Forecast, By Method (USD Million)

6.1    Key trends, by method

6.2    Microencapsulation

6.3    Macroencapsulation

6.4    Nanoencapsulation

Chapter 7   Live Cell Encapsulation Market Size and Forecast, By Application (USD Million)

7.1    Key trends, by application

7.2    Drug Delivery

7.3    Regenerative Medicine

7.4    Cell Transplantation

7.5    Other Applications

Chapter 8   Live Cell Encapsulation Market Size and Forecast, By Region (USD Million)

8.1    Key trends, by region

8.2    North America

8.2.1    U.S.

8.2.2    Canada

8.3    Europe

8.3.1    Germany

8.3.2    UK

8.3.3    France

8.3.4    Spain

8.3.5    Italy

8.3.6    Poland

8.3.7    Switzerland

8.3.8    Netherlands

8.3.9    Rest of Europe

8.4    Asia Pacific

8.4.1    Japan

8.4.2    China

8.4.3    India

8.4.4    Australia

8.4.5    South Korea

8.4.6    Thailand

8.4.7    Indonesia

8.4.8    Vietnam

8.4.9    Rest of Asia Pacific

8.5    Latin America

8.5.1    Brazil

8.5.2    Mexico

8.5.3    Argentina

8.5.4    Columbia

8.5.5    Chile

8.5.6    Peru

8.5.7    Rest of Latin America

8.6    MEA

8.6.1    South Africa

8.6.2    Saudi Arabia

8.6.3    UAE

8.6.4    Israel

8.6.5    Rest of MEA

Chapter 9   Company Profiles

9.1    Austrianova

9.2    Merck KGaA

9.3    Sphere Fluidics Limited

9.4    Blacktrace Holdings Ltd.

9.5    BIO INX

9.6    Isogen

9.7    Diatranz Otsuka Ltd

9.8    PharmaCyte Biotech, Inc.

9.9    Atelerix Ltd.

9.10    Neurotech Pharmaceuticals, Inc.

9.11    Buchi Labortechnik AG
 

Authors: Mariam Faizullabhoy, Gauri Wani

Buy Now


Premium Report Details

  • Base Year: 2022
  • Companies covered: 11
  • Tables & Figures: 354
  • Countries covered: 32
  • Pages: 180
 Download PDF